Locations:
Search IconSearch

Research

18-NEU-781-Recinos-Epigenetic-Targeting-650×450
May 7, 2018/Cancer

Epigenetic Targeting: A New Avenue in the Fight Against Pediatric High-Grade Glioma

An array of investigations underway at Cleveland Clinic

18-NEU-733-Pediatric-MS-650×450

Pediatric-Onset MS: Study Confirms Some Features, Flags Others as Research Priorities

Notable cohort findings include abnormal saccadic eye movements, use of second-line DMTs

18-NEU-823-Hantus-EEG-650×450
April 26, 2018/Neurosciences/Research

How Long to Monitor with cEEG? New Data Help Shape Choices

Large study gives guidance based on mental status, seizure etiology

18-NEU-817-Foldvary-Sleep-Neuro-650×450
April 22, 2018/Neurosciences/Research

High Prevalence of Insomnia and Sleep Apnea Found Among Patients with Diverse Neuro Diseases

Should sleep history be incorporated into routine neurological care?

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-NEU-736-Friedman-Pediatric-Stroke-650×450
April 20, 2018/Neurosciences/Research

VIPS II Study Homes In on Pediatric Arterial Ischemic Stroke

A key focus is characterizing arteriopathy, a prime predictor of recurrence

18-NEU-810-Stroke-Rehab-Katzan-650×450 (003)
April 13, 2018/Geriatrics

Post-Stroke Health Impacts Merit New Emphases in Stroke Survivor Care

Executive function, social roles and physical function loom large in new study

18-NEU-678-Progressive MS-650×450
March 23, 2018/Neurosciences/Research

Disability Progression Slowed for First Time in Large Trial of Secondary Progressive MS

Phase 3 EXPAND trial suggests potential utility of siponimod

18-NEU-505-Fernandez-Parkinson-Spark
March 12, 2018/Neurosciences/Research

Disease-Modifying Parkinson Therapy Is Put to the Test in Phase 2 Trial

Novel monoclonal antibody takes aim at alpha-synuclein clusters

18-NEU-618-Vogelbaum-Brain-Tumor-650×450
March 1, 2018/Cancer

In Brain Tumor Therapeutics, Options for Bypassing the Blood-Brain Barrier Are Burgeoning

Cleveland Clinic offers an abundance of direct delivery trials

18-NEU-687 Yan-650×450

Reversal of Alzheimer’s in Mouse Model Boosts BACE1 Inhibitors’ Prospects in Humans

Most substantial reversal of amyloid deposition in an animal study to date

BackPage 12 of 23Next

Advertisement

Ad